Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease.

David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q, Garcia R, Robert PH, Yesavage JA, Zeitzer JM; Alzheimer’s Disease Neuroimaging Initiative..

J Alzheimers Dis. 2011;27(1):155-61. doi: 10.3233/JAD-2011-110491.

PMID:
21785189
2.

Catechol-O-methyltransferase genetic variant associated with the risk of Alzheimer's disease in a Brazilian population.

Pereira PA, Romano-Silva MA, Bicalho MA, de Moraes EN, Malloy-Diniz L, Pimenta GJ, Mello MP, Bozzi IC, de Marco LA, Nicolato R, Miranda DM.

Dement Geriatr Cogn Disord. 2012;34(2):90-5.

PMID:
22922787
3.

Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.

Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S, Caimi L, Padovani A.

Neurobiol Aging. 2007 Aug;28(8):1231-8.

PMID:
16837108
4.

Association study of two steroid biosynthesis genes (COMT and CYP17) with Alzheimer's disease in the Italian population.

Corbo RM, Gambina G, Broggio E, Scarabino D, Scacchi R.

J Neurol Sci. 2014 Sep 15;344(1-2):149-53. doi: 10.1016/j.jns.2014.06.045.

PMID:
25012481
5.

Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.

Lanni C, Garbin G, Lisa A, Biundo F, Ranzenigo A, Sinforiani E, Cuzzoni G, Govoni S, Ranzani GN, Racchi M.

J Alzheimers Dis. 2012;32(4):919-26. doi: 10.3233/JAD-2012-120358.

PMID:
22890094
6.

Apathy is associated with a single-nucleotide polymorphism in a dopamine-related gene.

Mitaki S, Isomura M, Maniwa K, Yamasaki M, Nagai A, Nabika T, Yamaguchi S.

Neurosci Lett. 2013 Aug 9;549:87-91. doi: 10.1016/j.neulet.2013.05.075.

PMID:
23769684
7.

Lack of association between COMT Val158Met polymorphism and late-onset Alzheimer's disease in Han Chinese.

Zhou J, Li XM, Jiang T, Liu Y, Chi S, Yu JT, Tan L.

Neurosci Lett. 2013 Oct 25;554:162-6. doi: 10.1016/j.neulet.2013.09.006.

PMID:
24035893
8.

Association between the catechol-O-methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese population.

Shibata N, Nagata T, Tagai K, Shinagawa S, Ohnuma T, Kawai E, Kasanuki K, Shimazaki H, Toda A, Tagata Y, Nakada T, Nakayama K, Yamada H, Arai H.

Int J Geriatr Psychiatry. 2015 Sep;30(9):927-33. doi: 10.1002/gps.4237.

PMID:
25491588
9.

COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.

Lee YH, Song GG.

Neurol Sci. 2014 May;35(5):643-51. doi: 10.1007/s10072-014-1645-4. Review.

PMID:
24477323
10.

Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia.

Forero DA, Benítez B, Arboleda G, Yunis JJ, Pardo R, Arboleda H.

Neurosci Res. 2006 Jul;55(3):334-41.

PMID:
16698101
11.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
12.

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.

Martínez MF, Martín XE, Alcelay LG, Flores JC, Valiente JM, Juanbeltz BI, Beldarraín MA, López JM, Gonzalez-Fernández MC, Salazar AM, Gandarias RB, Borda SI, Marqués NO, Amillano MB, Zabaleta MC, de Pancorbo MM.

BMC Neurosci. 2009 Sep 30;10:125. doi: 10.1186/1471-2202-10-125.

13.

Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia.

Wang Y, Fang Y, Shen Y, Xu Q.

Psychiatry Res. 2010 Sep 30;179(2):147-50. doi: 10.1016/j.psychres.2009.03.029.

PMID:
20483479
14.

Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms.

Borroni B, Grassi M, Agosti C, Costanzi C, Archetti S, Franzoni S, Caltagirone C, Di Luca M, Caimi L, Padovani A.

Neurobiol Aging. 2006 Nov;27(11):1595-603.

PMID:
16257094
15.

Association between polymorphism of COMT gene (Val158Met) with Alzheimer's disease: An updated analysis.

Yan W, Zhao C, Sun L, Tang B.

J Neurol Sci. 2016 Feb 15;361:250-5. doi: 10.1016/j.jns.2016.01.014.

PMID:
26810551
16.

Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia.

Proitsi P, Lupton MK, Reeves SJ, Hamilton G, Archer N, Martin BM, Iyegbe C, Hollingworth P, Lawlor B, Gill M, Brayne C, Rubinsztein DC, Owen MJ, Williams J, Lovestone S, Powell JF.

Neurobiol Aging. 2012 Apr;33(4):791-803. doi: 10.1016/j.neurobiolaging.2010.06.011.

PMID:
20685009
17.

Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort.

Wright GE, Niehaus DJ, van der Merwe L, Koen L, Korkie LJ, Kinnear CJ, Drögemöller BI, Warnich L.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):163-9. doi: 10.1016/j.pnpbp.2012.06.006.

PMID:
22705295
18.

COMT haplotype analyses in Malaysians with schizophrenia.

Tee SF, Tang PY, Loh HC.

Psychiatry Res. 2012 Jan 30;195(1-2):83-4. doi: 10.1016/j.psychres.2011.07.039.

PMID:
21872942
19.

Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease.

Lin WY, Wu BT, Lee CC, Sheu JJ, Liu SH, Wang WF, Tsai CH, Liu HP, Tsai FJ.

J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3):401-10.

PMID:
23034259
20.

COMT polymorphisms and anxiety-related personality traits.

Stein MB, Fallin MD, Schork NJ, Gelernter J.

Neuropsychopharmacology. 2005 Nov;30(11):2092-102.

Items per page

Supplemental Content

Support Center